Home
/
IDEXX LABORATORIES INC /DE
/
Financials
/
Quarterly
IDEXX LABORATORIES INC /DE — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IDEXX LABORATORIES INC /DE filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.11B
Nov 3, 2025
Q2
2025
Jun 30, 2025
$1.11B
Aug 4, 2025
Q1
2025
Mar 31, 2025
$998.43M
May 1, 2025
Q3
2025
Sep 30, 2024
$975.54M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$1.00B
Aug 4, 2025
Q1
2025
Mar 31, 2024
$964.10M
May 1, 2025
Q3
2024
Sep 30, 2023
$915.53M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$943.63M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$900.20M
May 1, 2024
Q3
2023
Sep 30, 2022
$841.66M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$860.55M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$836.55M
May 2, 2023
Q3
2022
Sep 30, 2021
$810.42M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$826.14M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$777.71M
May 4, 2022
Q3
2021
Sep 30, 2020
$721.79M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$637.59M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$626.34M
May 4, 2021
Q3
2020
Sep 30, 2019
$605.30M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$620.10M
Jul 31, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$491.98M
Oct 31, 2017
Q2
2017
Jun 30, 2017
$508.94M
Aug 1, 2017
Q1
2017
Mar 31, 2017
$462.02M
Apr 28, 2017
Q3
2017
Sep 30, 2016
$448.31M
Oct 31, 2017
Q2
2017
Jun 30, 2016
$466.57M
Aug 1, 2017
Q1
2017
Mar 31, 2016
$417.55M
Apr 28, 2017
Q3
2016
Sep 30, 2015
$406.39M
Nov 1, 2016
Q2
2016
Jun 30, 2015
$413.34M
Aug 2, 2016
Q1
2016
Mar 31, 2015
$382.48M
Apr 29, 2016
Q3
2015
Sep 30, 2014
$383.52M
Oct 28, 2015
Q2
2015
Jun 30, 2014
$390.12M
Jul 30, 2015
Q1
2015
Mar 31, 2014
$360.20M
Apr 28, 2015
Q3
2014
Sep 30, 2013
$338.30M
Oct 24, 2014
Q2
2014
Jun 30, 2013
$352.58M
Jul 25, 2014
Q1
2014
Mar 31, 2013
$332.11M
Apr 25, 2014
Q3
2013
Sep 30, 2012
$315.48M
Oct 22, 2013
Q2
2013
Jun 30, 2012
$335.65M
Jul 23, 2013
Q1
2013
Mar 31, 2012
$322.68M
Apr 23, 2013
Q3
2012
Sep 30, 2011
$300.95M
Oct 19, 2012
Q2
2012
Jun 30, 2011
$317.86M
Jul 20, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$274.61M
Nov 3, 2025
Q3
2025
Jun 30, 2025
$293.99M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$293.99M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$242.68M
May 1, 2025
Q2
2025
Mar 31, 2025
$242.68M
Aug 4, 2025
Q3
2025
Mar 31, 2025
$242.68M
Nov 3, 2025
Q3
2025
Sep 30, 2024
$232.84M
Nov 3, 2025
Q3
2025
Jun 30, 2024
$203.30M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$203.30M
Aug 4, 2025
Q3
2025
Mar 31, 2024
$235.58M
Nov 3, 2025
Q2
2025
Mar 31, 2024
$235.58M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$235.58M
May 1, 2025
Q3
2024
Sep 30, 2023
$212.23M
Oct 31, 2024
Q3
2024
Jun 30, 2023
$224.24M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$224.24M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$214.05M
May 1, 2024
Q2
2024
Mar 31, 2023
$214.05M
Aug 6, 2024
Q3
2024
Mar 31, 2023
$214.05M
Oct 31, 2024
Q3
2023
Sep 30, 2022
$180.94M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$131.98M
Aug 1, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$354.85M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$373.05M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$316.53M
May 1, 2025
Q3
2025
Sep 30, 2024
$303.89M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$263.80M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$298.96M
May 1, 2025
Q3
2024
Sep 30, 2023
$275.28M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$296.14M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$280.40M
May 1, 2024
Q3
2023
Sep 30, 2022
$244.83M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$179.07M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$248.34M
May 2, 2023
Q3
2022
Sep 30, 2021
$225.96M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$259.25M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$247.62M
May 4, 2022
Q3
2021
Sep 30, 2020
$171.86M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$193.25M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$144.33M
May 4, 2021
Q3
2020
Sep 30, 2019
$139.80M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$164.28M
Jul 31, 2020